Podcasts about jama cardiology

近日，来自美国西北大学范伯格医学院的研究团队，在著名期刊JAMA Cardiology上发表一篇重要研究论文。他们在分析近5000人长达14.2年的随访数据首次发现，18-45岁之间的“生命8要素”（LE8）累积积分越高，45岁之后患心血管疾病和死亡的风险越低。这也再次提示大家，健康并不是短跑冲刺，而是一场终身的马拉松。

Interview with Leonoor F. J. M. Wijdeveld, BSc and Sean J. Jurgens, MD, MSc, PhD, authors of Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation. Hosted by Sharlene Day, MD. Related Content: Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation Genetic Testing in Early-Onset Atrial Fibrillation

Interview with Alexander C. Fanaroff, MD, MHS, author of Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation: Two Cluster Randomized Clinical Trials. Hosted by Ann Marie Navar, MD, PhD. Related Content: Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation

EBR Systems Inc Senior Vice President Andrew Shute talked with Proactive at the AIM maSmall and Midcap Conference about the company's upcoming FDA decision for its leadless CRT pacemaker system. The device is designed to treat heart failure and represents the only leadless option in a market currently dominated by three players—with no direct competitor. Shute said, “We've developed the world's only leadless pacemaker to treat heart failure. And we're on track to receive FDA approval within the next two and a half weeks.”* The product already holds FDA Breakthrough Device designation, and has shown strong clinical results, including a 16.4% reduction in left ventricular end systolic volume—well above the target goal of 9.3%. Shute outlined the company's go-to-market plan, emphasizing that reimbursement is expected to begin from October 1st under the NTAP and TPT schemes, enabling an ASP of USD 45,000. The company only needs to sell around 2,200 units annually to reach USD 100 million in revenue. “We've got no direct competition,” he said. He also highlighted the successful completion of the FDA's pre-approval inspection with no observations—an uncommon achievement in the medical device industry. The device, supported by data published in JAMA Cardiology, was also featured at the Heart Rhythm Society meeting in 2023. During the interim, the US commercial team will establish purchasing agreements, prepare technology committee engagements, and begin physician training for a limited market release. #EBRSystems #MedicalDevices #HeartFailureTreatment #LeadlessPacemaker #CardiacTech #FDAApproval #CRTDevice #InvestingInHealthcare #BreakthroughDevice #MedTechInnovation #JAMACardiology #HeartRhythmSociety

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy. JAMA Cardiology 2025. Discussion by:Guest: Michael J. Blaha, MD, MPHProfessor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for theJohns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease2. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine. Discussion by:Guest:Amreen Syed, DO Resident– Family Medicine Residency ProgramJefferson Health – Abington3. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis Journal of Allergy and Clinical Immunology in Practice3. Discussion by:Guest:Michelle Buchbinder, MDResident – Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Send us a text about this episode.Send us a text about this episode. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this special episode on Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) our host, Dr. Neil Skolnik will lead a case-based discussion on HFpEF, presenting challenges and integration of emerging evidence into clinical practice. This special episode is supported by an independent educational grant from Roche. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Susan Kuchera, M.D. - Clinical Assistant Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University and Program Director of the Family Medicine Residency at Jefferson Health Abington. Muthu Vaduganathan M.D. - Cardiologist and Co-Director, Center for Cardiometabolic Implementation Science at Brigham and Women's Hospital and Harvard Medical School; Associate Editor of the Journal of the American College of Cardiology.   Selected references referred to the in the Podcast: Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association.  Diabetes Care 2022  2023 American College of Cardiology Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction (HFpEF). Journal of the American College of Cardiology 2023 Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiology 2022;7(12):1259-1263    

Lung ultrasound aids in the diagnosis of patients with dyspnea but requires technical proficiency for image acquisition. Cristiana Baloescu, MD, MPH, of Yale School of Medicine, joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to discuss a new study published in JAMA Cardiology evaluating the ability of AI to guide acquisition of diagnostic-quality lung ultrasound images by trained health care professionals. Related Content: AI-Guided Lung Ultrasounds Could Help Nonexpert Clinicians Acquire “Expert-Level” Images Artificial Intelligence–Guided Lung Ultrasound by Nonexperts

Join @coach.noush_dpt as she discusses this study published in JAMA Cardiology that looked at over 5900 women aged 63 to 99 to see how their daily movement patterns affects their risk of developing heart failure.   Want to make sure you stay on top of all things geriatrics? Go to https://MMOA.online to check out our Free eBooks, Lectures, & the MMOA Digest!

Interview with Thomas Gaziano, MD, author of Sodium Reduction Legislation and Urinary Sodium and Blood Pressure in South Africa, and Daniel W. Jones, MD, author of Dietary Sodium- and Potassium-Enriched Salt Substitutes—The Tipping Point? Hosted by Ann Marie Navar, MD, PhD. Related Content: Sodium Reduction Legislation and Urinary Sodium and Blood Pressure in South Africa Dietary Sodium- and Potassium-Enriched Salt Substitutes—The Tipping Point?

A case so unusual it made it to the medical journals. Dr. Kostas Marmagkiolis, a cardiologist with Tampa Heart and Vascular who's affiliated with Tampa General Hospital, co-wrote an article for JAMA Cardiology about a local patient. The man had a yellow rash on his hands and feet that the doctor identified as a sign of extremely high cholesterol. Listen to find out what drove his levels so high.

A new study from JAMA Cardiology reveals that more than half of U.S. adults are eligible for Ozempic or Wegovy. Also, Cher sits down one-on-one with Hoda to discuss the release of her new memoir, Cher, The Memoir: Part One. Plus, jump-start your holiday shopping with a few great discounts on gifts of up to 82 percent off. And, Jessica Seinfeld talks about being 'empty nesters,' her family's thoughts on the Mets, and her new cookbook featuring desserts for any diet.

A recent JAMA Cardiology essay argues that medicine is not just a technical endeavor, it's also a moral endeavor, and a robot does not have moral agency. Coauthor Sarah C. Hull, MD, MBE, of Yale School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss the use of AI in managing decision-making in cardiac care. Related Content: AI Can't Worry About Patients, and a Clinical Ethicist Says That Matters Echoes of Concern—AI and Moral Agency in Medicine

Interview with Barry A. Borlaug, MD, and Jwan A. Naser, MBBS, authors of Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation. Hosted by James E. Udelson, MD. Related Content: Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation

Interview with Paul L. Hess, MD, MHS, and Vincenzo B. Polsinelli, MD, authors of Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs. Hosted by James E. Udelson, MD. Related Content: Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs

Interview with Luis R. Lopes, PhD, author of Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population, and Senthil Selvaraj, MD, MS, MA, author of Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection. Hosted by Sharlene M. Day, MD. Related Content: Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection

Interview with Jagmeet P. Singh, MD, DPhil, author of Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure. Hosted by Kristen K. Patton, MD. Related Content: Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure

In this episode of Cardiology Digest, we dive into top journals like JAMA Cardiology to bring you three of the most compelling recent research papers from the field of cardiology. STUDY #1: First, see how the new Boston Scientific cryoballoon measures up against Medtronic's product. Did the newcomer outshine the veteran, or does it come with hidden risks? Discover the head-to-head results and what they mean for the future of atrial fibrillation cryoablation.  Reichlin, T, Kueffer, T, Knecht, S et al. 2024. PolarX vs Arctic Front for cryoballoon ablation of paroxysmal AF: The randomized COMPARE CRYO study. JACC Clin Electrophysiol. In Press, Corrected Proof. (https://doi.org/10.1016/j.jacep.2024.03.021) STUDY #2: Next, we explore the intersection of aging, aortic stenosis, and osteosarcopenia in elderly patients undergoing transcatheter aortic valve replacement. This study highlights a radiographic method that reveals a high-risk subpopulation within this demographic. See how this insight can shape our approach to transcatheter aortic valve replacement, and what it means for patient care strategies. Solla-Suarez, P, Arif, S, Ahmad, F, et al. 2024. Osteosarcopenia and mortality in older adults undergoing transcatheter aortic valve replacement. JAMA Cardiol. 7: 611-618. (https://doi.org/10.1001/jamacardio.2024.0911) O'Gara, P, Guduguntla, V, Bonow, R, et al. 2024, Osteosarcopenia and mortality after transcatheter aortic valve replacement. JAMA Cardiol. 7: 618-619. (https://doi.org/10.1001/jamacardio.2024.1018) STUDY #3: Finally, we turn our attention to the pressing issue of hypertensive disorders in pregnancy. Discover why close postpartum monitoring is critical and what the latest research suggests about the persistence of hypertension in new mothers. Could longer follow-ups hold the key to better postpartum care? Hauspurg, A, Venkatakrishnan, K, Collins, L, et al. 2024. Postpartum ambulatory blood pressure patterns following new-onset hypertensive disorders of pregnancy. JAMA Cardiol. Published online (https://doi.org/10.1001/jamacardio.2024.1389) Join us to unravel these important studies and their implications for your practice and patients. Ready to stay ahead in the rapidly evolving world of cardiology? Hit play and let's get started!  Learn more with Medmastery's courses: Holter Monitoring Essentials (2 CME) Get a Basic or Pro account, or, get a Trial account. Show notes: Visit us at  https://www.medmastery.com/podcasts/cardiology-podcast.

Hypertensive disorders of pregnancy (HDP), including chronic hypertension, gestational hypertension, and pre-eclampsia, are increasingly common in the United States, complicating close to 15% of births, and the incidence is continuing to rise! On this show we have addressed medical management of urgent hypertension in pregnancy and in the immediate postpartum interval. This topic continues to EVOLVE, with a brand new study which has gained a lot of medical news attention. This new study was published in JAMA CARDIOLOGY on June 12, 2024 and is helping redefine the "BP cut off" for medication use in the pp interval. AND...this is evolving within the ACOG as well! We have LOTS of late breaking news to cover here....so listen in!

Interview with Alisse Hauspurg, MD, MS, author of Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy. Hosted by Sadiya S. Khan, MD, MSc. Related Content: Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy

Interview with Jonathan Afilalo, MD, MSc, author of Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement. Hosted by Robert O. Bonow, MD. Related Content: Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement

ACC Part 2: The TACT2 trial of chelation, inter-atrial shunts for HF, and triglyceride lowering; plus diltiazem and Factor Xa anticoagulants are the topics John Mandrola, MD, covers this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. TACT 2 Chelation Therapy Provides No Benefit Post-MI https://www.medscape.com/viewarticle/chelation-therapy-provides-no-benefit-post-mi-2024a10006l5 Chelation Therapy and CV Risk: Why TACT2 Showed No Benefit https://www.medscape.com/viewarticle/chelation-therapy-and-cv-risk-why-tact2-showed-no-benefit-2024a1000761?src= JAMA TACT 1 paper https://jamanetwork.com/journals/jama/fullarticle/1672238 Diabetes Subgroup paper https://pubmed.ncbi.nlm.nih.gov/24254885/ A New Look at P-values https://evidence.nejm.org/doi/abs/10.1056/EVIDoa2300003 PARAGON HF https://www.nejm.org/doi/full/10.1056/NEJMoa1908655 II. Interatrial Shunts for HF No Net HF Benefit for Interarterial Shunt Device https://www.medscape.com/viewarticle/no-net-hf-benefit-interarterial-shunt-device-2024a10006kk REDUCE LAP HF II https://doi.org/10.1016/S0140-6736(22)00016-2 III. Triglyceride Lowering Early Olezarsen Results Show 50% Reduction in Triglycerides https://www.medscape.com/viewarticle/early-olezarsen-results-show-50-reduction-triglycerides-2024a10006oz Is It Time to Stop Treating High Triglycerides? https://www.medscape.com/viewarticle/990126 NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2402309 Substantial Triglyceride Reduction With Plozasiran https://www.medscape.com/viewarticle/substantial-triglyceride-reduction-plozasiran-2024a10006wf?icd=login_success_email_match_norm JAMA Cardiology https://jamanetwork.com/journals/jamacardiology/article-abstract/2817469 IV. Diltiazem and Factor Xa inhibitors JAMA Vanderbilt University Paper https://jamanetwork.com/journals/jama/fullarticle/2817546 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Interview with Sanjiv J. Shah, MD, author of Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

Interview with Gaurav A. Upadhyay, MD, and Jeremy S. Treger, MD, PhD, authors of A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. Hosted by Kristen K. Patton, MD. Related Content: A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I

Interview with Michael T. Lu, MD, MPH, author of Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial, and Matthew J. Feinstein, MD, MSc, author of Statins, Inflammation, and Tissue Context in REPRIEVE. Hosted by Robert Bonow, MD. Related Content: Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV Statins, Inflammation, and Tissue Context in REPRIEVE

Interview with Sanjiv J. Shah, MD, author of Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive

Dr. Katie Young, co-director of the cardioobstetrics clinic here at Mayo Clinic sits down to talk about peripartum cardiomyopathy. This is something we will likely consider many times in our careers for patients with shortness of breath in and around late pregnancy. Find out what interventions are key, what patients are most likely to suffer a bad outcome and more. CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch Email - AlwaysOnEM@gmail.com REFERENCES & LINKS Gierula J, et al. Prospective evaluation and long-term follow up of patients referred to secondary care based upon natriuretic peptide levels in primary care. European Heart Journal – Quality of Care and Clinical Outcomes. 2019. 5, 218-224 Bay M, et al. NT-proBNP: A new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart. 2003. 89,150-154 Dockree S, et al. Pregnancy reference intervals for BNP and NT-pro BNP – changes in natriuretic peptides related to pregnancy. Journal of Endocrine society. 2021. 5(7)1-9 Mueller C, et al. Heart failure association of the European society of cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure. 2019. 21, 715-731 Ravichandran J, et al. High-sensitivity cardiac troponin I levels in normal and hypertensive pregnany. American J of Medicine. 2019. 132,362-366 High sensitivity troponin T and I among pregnant women in the US – the National Health and Nutrition Examination Survey. JAMA Cardiology. 2023. 8(4)406-408 Tweet MS, et al. Spontenaoues Cardic Artey Dissection associated with pregnancy. Journal of the American College of Cardiology. 2017. 70,426-435 Baggish AL, et al. The differential diagnosis of an elevated amino-terminal Pro-B-Type Natriuretic Peptide level. Am J Cardiol. 2008. 101,43A-48A Lichtenstein DA, Meziere GA. Relevance of lung ultrasound in the diagnosis of acute Respiratory Failure – the Blue Protocol. Chest. 2008. 134,117-125 Smit MR, et al. Comparison of linear and sector array probe for handheld lung ultrasound in invasively ventilated ICU patients. Ultrasound in Med & Biol. 2020. 46(12)3249-3256 Haller EP, Nestler DM, Campbell RL, Bellamkond VA. Point-of-care ultrasound findings of acute pulmonary embolism: McConnell sign in the emergency medicine. JEM. 2014. 47(1)e19-e24 Halpern DG, et al. Use of medication for cardiovascular disease during pregnancy:JACC State of the Art Review. J Am Coll Cardiol. 2019. Feb, 73(4)457-476 Loyanga-Rendon RY, et al. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. 2014. Circ Heart Failure. 7,300-309 Adedinsewo DA, et al. Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model. European Heart Journal – Digital Health. 2021. 2,586-596 Zieleskiewicz L., et al. Lung ultrasound-guided management of acute breathlessness during pregnancy. Anesthesia. 2013. 68,97-101 Balaceanu A. B-type natriuretic peptides in pregnant women with normal heart or cardiac disorders. Medical Hypotheses. 2018. 121,149-151

Interview with Muthiah Vaduganathan, MD, MPH, and John W. Ostrominski, MD, authors of Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. Hosted by Sadiya Sana Khan, MD, MSc. Related Content: Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

Interview with Maria C. Magnus, PhD, author of Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies, and Sadiya S. Khan, MD, MSc, author of Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter. Hosted by Roxana Mehran, MD Related Content: Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter

Interview with Marianna Fontana, MD, PhD, author of Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping, and Sarah A. M. Cuddy, MB, BCh, BAO, author of Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis. Hosted by James Udelson, MD. Related Content: Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis

Interview with Robert W. Yeh, MD, MSc, author of Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock, and David J. Cohen, MD, MSc, and Manesh R. Patel, MD, authors of Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart. Hosted by Ajay J. Kirtane, MD, SM. Related Content: Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart

Michelle Kittleson, MD (@MKittlesonMD) drops pearls from her new book, Mastering the Art of Patient Care, around how to be a leader and navigate transitions in health profession education.  She shares relatable anecdotes and valuable tips on how to prepare for leadership, navigate uncertainty, and build your mentor cabinet.  Claim free CME for this episode at curbsiders.vcuhealth.org! Website | Instagram | Twitter | Subscribe | Patreon | Free CME!| Youtube Dr Michelle Kittleson is Professor of Medicine at Cedars-Sinai and Director of Education in Heart Failure and Transplantation at the Smidt Heart Institute. Dr. Kittleson is Deputy Editor of the Journal of Heart and Lung Transplantation, on writing committees for the 2020 Hypertrophic Cardiomyopathy Guidelines and the 2022 HF Guidelines, and on the Board of Directors for the Heart Failure Society of America. Her essays have appeared in the New England Journal of Medicine, Annals of Internal Medicine, and JAMA Cardiology and poems in JAMA and Annals of Internal Medicine. Her book, Mastering the Art of Patient Care, is available from Springer publishing. Show Segments Intro, disclaimer, guest bio Guest one-liner/ Best piece of advice Picks of the Week Case from Kashlak Leadership development in medicine Senior Resident Transition Kittleson's Rounds Encouraging Healthy Debate Kindness as a Leader Mentor Support Dealing with Uncertainty Tips to reduce micromanaging Take home Points Outro Credits Writer: John Ong, DO CME: John Ong, DO Infographic: Charlotte Chaiklin, MD Cover Art: Charlotte Chaiklin, MD Hosts: Era Kryzhanovskaya MD; Molly Heublein MD; John Ong DO   Show Notes: John Ong DO; Era Kryzhanovskaya MD Editor: (audio) podpaste (written materials) Molly Heublein MD Guest: Michelle Kittleson MD

Interview with Sharlene M. Day, MD, Rachel Lampert, MD, and Michael J. Ackerman, MD, PhD, authors of Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. Hosted by Robert Bonow, MD. Related Content: Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy

Interview with Ajay J. Kirtane, MD, SM, author of Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. Hosted by Clyde W. Yancy, MD, MSc. Related Content: Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials Is There a Role for Renal Denervation in the Treatment of Hypertension?

Guest Carolyn Ho, MD, discusses genetic testing and precision medicine. How can we improve the information we get as part of gathering family history? What role does genetic testing play in in clinical practice--and how can we work collaboratively with our patients and their families to better understand the process and results? Allison Cirino, Role of Genetic Testing in Inherited CVD, JAMA Cardiology: https://jamanetwork.com/journals/jamacardiology/article-abstract/2647085?redirect=true See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Interview with Jenica N. Upshaw, MD, MS, author of Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma, and Ana Barac, MD, PhD, author of Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango. Hosted by Robert Bonow, MD. Related Content: Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango

Interview with Søren Zöga Diederichsen, MD, PhD, author of Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care: Post Hoc Analysis of the LOOP Randomized Clinical Trial, and Mark Schoenfeld, MD, author of Incidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences. Hosted by Kristen K. Patton, MD. Related Content: Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care Incidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences

Dr. Lee Mancini reviews the article, “Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening,” which was originally published in the JAMA Cardiology in March 2021. Dr. Jeremy Schroeder serves as moderator. Dr. Mancini is the Co-Chair of the Top Articles Subcommittee, and this episode is part of an ongoing mini journal club series highlighting each of the Top Articles in Sports Medicine from 2021, as selected for the 2022 AMSSM Annual Meeting in Austin, TX. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. DOI: 10.1001/jamacardio.2021.0565

Interview with Michael J. Reardon, MD, and Daniel O'Hair, MD, authors of Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. Hosted by Robert O. Bonow, MD, MS. Related Content: Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Interview with Mitesh S. Patel, MD, MBA, author of Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial, and Faraz S. Ahmad, MD, MS, author of Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both. Hosted by Sadiya Sana Khan, MD, MS. Related Content: Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both

JAMA Interim Executive Editor Gregory Curfman, MD, interviews Robert M. Carey, MD, University of Virginia, about his review article on treatment of hypertension in the November 8, 2022, issue of JAMA. Their discussion addresses the clinical consequences of hypertension, as well as nonpharmacological and pharmacological approaches to management, including patients with resistant hypertension. Related Content: Treatment of Hypertension More programs like this one are available via the JAMA Clinical Reviews podcast.

Interview with Nicholas M. Pajewski, PhD, author of Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial, and Daniel W. Jones, MD, author of Blood Pressure Control After SPRINT—Back to Reality. Hosted by Gregg C. Fonarow, MD. Related Content: Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control Blood Pressure Control After SPRINT—Back to Reality

Interview with Santhi K. Ganesh, MD, author of Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features, and Sharonne N. Hayes, MD, author of Genetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise. Hosted by Sadiya Sana Khan, MD, MS. Related Content: Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features Genetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise

Interview with Tariq Ahmad, MD, MPH, author of Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure: The REVEAL-HF Randomized Clinical Trial, and Rishi K. Wadhera, MD, MPP, MPhil, author of Improving Quality Improvement—From Aspiration Toward Empiricism. Hosted by Gregg C. Fonarow, MD. Related Content: Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure Improving Quality Improvement—From Aspiration Toward Empiricism

Interview with João L. Cavalcante, MD, author of Association of Left Ventricular Remodeling Assessment by Cardiac Magnetic Resonance With Outcomes in Patients With Chronic Aortic Regurgitation, and Vidhu Anand, author of Earlier Intervention in Asymptomatic Chronic Aortic Regurgitation—Novel Indicators of Myocardial Overload.Hosted by Robert Bonow, MD.

Interview with Ambarish Pandey, MD, MSCS, author of Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure, and Eldrin F. Lewis, MD, MPH, author of Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure. Hosted by Clyde W. Yancy, MD. Related Content: Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content: The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video) A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)

Interview with Aniruddh P. Patel, MD, author of Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality, and M. Benjamin Shoemaker, MD, author of Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes. Hosted by Sadiya Sana Khan, MD, MS.

Interview with Amil M. Shah, MD, MPH, and Peder L. Myhre, MD, PhD, authors of Sex and Race Differences in N-Terminal Pro–B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community. Hosted by Clyde Yancy, MD.

Interview with Sidney C. Smith, MD, author of Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China, and Hani Jneid, author of Insights and Opportunities in STEMI Care in China Hosted by Clyde Yancy, MD.